Characterization and engineering of a type IV-A3 CRISPR–Cas system for genome editing in Escherichia coli
Nucleic Acids Research · 26.11.2025 · 53 (22)
DOI: 10.1093/nar/gkaf1394 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 18.12.2025. Verfasst von Szabolcs Semsey und 11 weiteren Autor:innen. Beteiligte Einrichtung: SNIPR Biome ApS, 2100, Copenhagen, Denmark. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Escherichia coli, Gene Editing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: SNIPR Biome.
Abstract (Originalsprache)
CRISPR–Cas systems have revolutionized genome engineering technologies, but type IV CRISPR–Cas systems and their genome engineering potential have been critically underexplored. In this study, we identified a type IV-A3 CRISPR–Cas system from a clinical Klebsiella pneumoniae isolate and characterized its plasmid targeting activity and capacity to suppress chromosomal and plasmid gene expression in Escherichia coli. We revealed the pivotal role of Csf3 (Cas5) and the dispensable roles of Csf1 (Cas8-like) and Csf4 (DinG helicase) subunits in IV-A3 CRISPR–Cas complex formation. The system prevents plasmid propagation via interplay between DinG helicase activity and strategic protospacer positioning relative to plasmid replication and maintenance components. We enabled the IV-A3 CRISPR–Cas system to introduce lethal, sequence-specific double-stranded (ds)DNA breaks in the E. coli chromosome by fusing the nuclease domain of the I-TevI nuclease to the Cas8 N-terminus. Further, we developed a series of base editors, with various editing efficiencies and windows, by fusing the PmCDA1 cytidine deaminase to the Cas8, Cas5, and DinG subunits. Finally, conjugative transfer of the Cas5–PmCDA1 base editor into E. coli deactivated the tryptophan repressor gene, boosting IAA production. Our study provides new insights into type IV-A3 CRISPR–Cas systems and highlights their potential in genome engineering applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- SNIPR Biome ApS, 2100, Copenhagen, Denmark.
ORCID-Profile: Ioannis Mougiakos
Förderung
- SNIPR Biome
Zitieren
APA
Semsey, S., Søndberg, E., Røen, M., Hallström, B., Petersen, A. Ø., Alfastsen, L., Bosch, B. R., Wohl, B., Clube, J., van der Helm, E., Groendahl, C., & Mougiakos, I. (2025). Characterization and engineering of a type IV-A3 CRISPR–Cas system for genome editing in Escherichia coli. Nucleic Acids Research, 53(22). https://doi.org/10.1093/nar/gkaf1394
Vancouver
Semsey S, Søndberg E, Røen M, Hallström B, Petersen AØ, Alfastsen L, et al. Characterization and engineering of a type IV-A3 CRISPR–Cas system for genome editing in Escherichia coli. Nucleic Acids Research. 2025;53(22). doi:10.1093/nar/gkaf1394
BibTeX
@article{Semsey2025,
author = {Semsey, Szabolcs and Søndberg, Emilie and Røen, Mathilde and Hallström, Björn and Petersen, Anders Østergaard and Alfastsen, Lauge and Bosch, Berta Rosich and Wohl, Benjamin and Clube, Jasper and van der Helm, Eric and Groendahl, Christian and Mougiakos, Ioannis},
title = {Characterization and engineering of a type IV-A3 CRISPR–Cas system for genome editing in Escherichia coli},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {22},
doi = {10.1093/nar/gkaf1394}
}
EUVIMED